Related references
Note: Only part of the references are listed.Pentosan Polysulfate Maculopathy: Prevalence, Spectrum of Disease, and Choroidal Imaging Analysis Based on Prospective Screening
Derrick Wang et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2021)
Prevalence and Risk Factors of Tamoxifen Retinopathy
Hyun-Ah Kim et al.
OPHTHALMOLOGY (2020)
Pentosan Polysulfate Sodium Exposure and Drug-Induced Maculopathy in Commercially Insured Patients in the United States
Cassie A. Ludwig et al.
OPHTHALMOLOGY (2020)
Prevalence of Maculopathy Associated with Long-Term Pentosan Polysulfate Therapy
Robin A. Vora et al.
OPHTHALMOLOGY (2020)
Using Causal Diagrams to Improve the Design and Interpretation of Medical Research
Mahyar Etminan et al.
CHEST (2020)
Large Subfoveal Vitelliform Lesions in a Case of Pentosan Polysulfate Maculopathy
Kendall W. Wannamaker et al.
OPHTHALMOLOGY (2020)
Strength of Association between Pentosan Polysulfate and a Novel Maculopathy
Adam M. Hanif et al.
OPHTHALMOLOGY (2019)
Phenotypic Spectrum of Pentosan Polysulfate Sodium-Associated Maculopathy A Multicenter Study
Adam M. Hanif et al.
JAMA OPHTHALMOLOGY (2019)
THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: Introduction and Other Protein Targets
Stephen P. H. Alexander et al.
BRITISH JOURNAL OF PHARMACOLOGY (2019)
Pigmentary Maculopathy Associated with Chronic Exposure to Pentosan Polysulfate Sodium
William A. Pearce et al.
OPHTHALMOLOGY (2018)
Survival Analysis and the Immortal Time Bias
Craig Kollman
JAMA OPHTHALMOLOGY (2018)
Mutations in the Genes for Interphotoreceptor Matrix Proteoglycans, IMPG1 and IMPG2, in Patients with Vitelliform Macular Lesions
Caroline Brandl et al.
GENES (2017)
Penalization, bias reduction, and default priors in logistic and related categorical and survival regressions
Sander Greenland et al.
STATISTICS IN MEDICINE (2015)
Introduction to causal diagrams for confounder selection
Elizabeth J. Williamson et al.
RESPIROLOGY (2014)
The Risk of Toxic Retinopathy in Patients on Long-term Hydroxychloroquine Therapy
Ronald B. Melles et al.
JAMA OPHTHALMOLOGY (2014)
Number needed to treat is incorrect without proper time-related considerations
Daniel Suissa et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2012)
Problem of immortal time bias in cohort studies: example using statins for preventing progression of diabetes
Linda E. Levesque et al.
BRITISH MEDICAL JOURNAL (2010)
Immortal time bias in pharmacoepidemiology
Samy Suissa
AMERICAN JOURNAL OF EPIDEMIOLOGY (2008)
Share Paper
